Mark Nixon

Postdoctoral Research Fellow

  • Centre for Cardiovascular Science

Contact details

Address

Street

Queen's Medical Research Institute
Edinburgh Bioquarter
47 Little France Crescent

City
Edinburgh
Post code
EH16 4TJ

Research summary

Glucocorticoid excess, particularly in adipose tissue, drives increased cardiovascular disease risk, including visceral obesity, hyperglycemia, dyslipidemia, and hypertension. Thus, efforts to reduce glucocorticoid action in adipose tissue as a treatment for cardiometabolic disease have both scientific and clinical merit. Our research is focused on the delivery mechanism through which glucocorticoids are ‘targeted’ to metabolic tissues, with the aims of not only advancing our understanding of glucocorticoid action in cardiometabolic disease, but identifying novel pathways to limit adverse glucocorticoid exposure.

View all 12 publications on Research Explorer